Narrow search
Showing 1 - 10 of 46,736
Cover Image
Does in utero exposure to illness matter? : the 1918 influenza epidemic in Taiwan as a natural experiment
Lin, Ming-Jeng; Liu, Elaine M. - 2014
positive selection on health from high infant mortality rates during this period (18 percent), our findings suggest a strong …
Persistent link: https://www.econbiz.de/10010356829
Cover Image
Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction : microsimulation analysis of the 1999 nationwide french hospi...
Milcent, Carine; Dormont, Brigitte; Durand-Zaleski, Isabelle - Université Paris-Dauphine (Paris IX) - 2007
Background— Women with acute myocardial infarction have a higher hospital mortality rate than men. This difference has … study is to assess these factors in relation to excess mortality in women. Methods and Results— All hospital admissions in … regression on mortality was performed for age, comorbidities, and coronary interventions. Nonparametric microsimulation models …
Persistent link: https://www.econbiz.de/10011073006
Cover Image
Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001-7
Lichtenberg, Frank R. - In: PharmacoEconomics 30 (2012) 3, pp. 197-211
. The effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality … replacement of older drugs by newer drugs. The effect of the vintage of chemotherapy treatments on age-adjusted cancer mortality … mortality rates, and may have accounted for as much as half of the decline. …
Persistent link: https://www.econbiz.de/10009493381
Cover Image
Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction : microsimulation analysis of the 1999 nationwide french hospi...
Milcent, Carine; Dormont, Brigitte; Durand-Zaleski, Isabelle - Université Paris-Dauphine - 2007
Background— Women with acute myocardial infarction have a higher hospital mortality rate than men. This difference has … study is to assess these factors in relation to excess mortality in women. Methods and Results— All hospital admissions in … regression on mortality was performed for age, comorbidities, and coronary interventions. Nonparametric microsimulation models …
Persistent link: https://www.econbiz.de/10008790069
Cover Image
Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer: A Systematic Review of the Literature
GuyJr, Gery P. Guy; Ekwueme, Donatus U. - In: PharmacoEconomics 29 (2011) 10, pp. 863-874
systematically review the published literature on the YPLL and the value of productivity loss from morbidity and premature mortality … results on YPLL, eight on mortality costs and five on morbidity costs. Some studies reported results in more than one category … per death and morbidity and mortality costs. The average number of YPLL per death was approximately 15 for melanoma and 10 …
Persistent link: https://www.econbiz.de/10010614404
Cover Image
Does in utero Exposure to Illness Matter? The 1918 Influenza Epidemic in Taiwan as a Natural Experiment
Lin, Ming-Jen; Liu, Elaine M. - Institute for the Study of Labor (IZA) - 2014
positive selection on health from high infant mortality rates during this period (18 percent), our findings suggest a strong …
Persistent link: https://www.econbiz.de/10010891167
Cover Image
Insights Into Heaping From Retrospective Breastfeeding Data.
Klerman, J.A. - RAND - 1996
effect of breastfeeding on infant mortality. …
Persistent link: https://www.econbiz.de/10005775556
Cover Image
Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review
Coukell, Allan J.; Noble, Stuart; Faulds, Diana - In: PharmacoEconomics 15 (1999) 4, pp. 405-417
Vinorelbine is a semisynthetic vinca alkaloid that is effective against advanced non-small cell lung cancer (NSCLC). Myelosuppression is the primary dose-limiting toxicity; vinorelbine is otherwise relatively well tolerated. Two studies assessed the cost effectiveness of vinorelbine with or...
Persistent link: https://www.econbiz.de/10005590381
Cover Image
Treatment of Locally Advanced Pancreatic Carcinoma in Sweden: A Health Economic Comparison of Palliative Treatment With Best Supportive Care Versus Palliative Treatment With Gemcit...
Tennvall, Gunnel Ragnarsont; Wilking, Nils - In: PharmacoEconomics 15 (1999) 4, pp. 377-384
Objective. Patients with pancreatic cancer have only short survival after diagnosis, irrespective of treatment. The aim of this study was to perform a health economic evaluation of present standard treatment (in most cases, palliative treatment in combination with best supportive care) versus...
Persistent link: https://www.econbiz.de/10005590429
Cover Image
Decreased Medical Expenditures for Care of HIV-Seropositive Patients: The Impact of Highly Active Antiretroviral Therapy at a US Veterans Affairs Medical Center
Mole, Larry; Ockrim, Kimberly; Holodniy, Mark - In: PharmacoEconomics 16 (1999) 3, pp. 307-315
Objective: To identify any changes in expenditures and in morbidity and mortality with the progression of treatment of …, laboratory and prescription costs, and morbidity and mortality rates. Main outcome measures and results: The 3 periods had … immunosuppression (defined as CD4+ lymphocyte counts <500 cells/mm3). Morbidity and mortality were not changed by the addition of dual …
Persistent link: https://www.econbiz.de/10005590457